The use of anti-IL10 antibodies was also assayed in other inflammatory diseases, including psoriasis lesions; anti-IL10 antibody treatment upregulates IL-17A, which plays a central role in psoriasis pathogenesis [47]. Here, IL10 is linked to psoriasis.